ISSN 0974-3618 (Print) www.rjptonline.org
0974-360X (Online)
RESEARCH ARTICLE
Investigation
to find out the Root Cause for Presence of Broken Tablet in the Marketed
Blister Pack
Vamshi Krishna T, Lalit
Kumar, M. Sreenivasa Reddy, Rajat Rao, M. Ankineedu,
Girish Pai K*
Department of Pharmaceutics, Manipal
College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka
State, India-576104
*Corresponding Author E-mail: girish.pai@manipal.edu
ABSTRACT:
The main objective of this study was to find out the
root cause for broken tablet and black spots on tablets in primary pack of the
marketed product containing Diclofenac sodium 50 mg and Paracetamol500 mg. In
this study, we took tablets of same batch in which broken tablet (Batch A) was
found and another batch (Batch B) from the same company was procured (for
investigation) and they were evaluated for parameters like appearance, weight
variation, hardness and friability. The results of (Batch A) and (Batch B)
showed that weight variation, Friability was within
limit according to Indian pharmacopeia, Hardness
of both batcheswas found to be 9 kg.Based on the investigation, it was
concluded that there was no formulation defect in the Batch-A tablets.Breakage of the
tablet at the edge must be due to somephysical damage or some other reason.
This wasconcluded from results of friability, weight variation andhardness
tests. Appearance of black color spots on thetablet surface was not due to
formulation problem. Itmay be due to instrumental problems like excessive useof
oil- Based Lubricants etc. Finally to sum up, it isrecommended to carry out
100% tablet inspection beforeprimary packing activity which shall avoid
defectivetablets getting packed into blister.
Broken tablet found in
the (Batch A) was due to some physical damage or any other reason during
shipping and storage. Black colour spots found on the surface of the tablet may
be due excessive usage of oil lubricants, more amount fines in the powder blend.
INTRODUCTION:
The main objective of this study was to investigate and find out
the root cause for presence broken tablet with in marketed blister pack [1, 2
and 3]. The product is an uncoated tablet and a fixed dose combination product
containing 500 mg of paracetamoland 50 mg of diclofenac sodium [4]. The
research started after observing a broken tablet with in blister pocket [5].
This complaint was reported by one of the authors of this article. The product
was purchased from a famous medical shop in Udupi in Karnataka state, using the
doctor’s prescription. Pictures of the product were taken and shown in Figure
1.
Received on 01.06.2015
Modified on 20.06.2015
Accepted on 23.06.2015
© RJPT All right reserved
Research J. Pharm. and Tech. 8(6): June,
2015; Page 707-709
DOI: 10.5958/0974-360X.2015.00112.2
The probable cause may be due to one of the following reasons.
·
Improper
inspection of tablets after compression stage and primary packing stages
·
No
inspection carried out
·
Formulation
problems: Inadequate concentration of binder, over drying of granules etc
·
Manufacturing
defects: Improper setting of compression machine
·
Improper
handling of uncoated tablets
Fig
1: Pictures of the product containing broken tablet
MATERIALS
AND METHODS:
MATERIALS:
Roche Friabilator, Monsanto hardness tester.
METHODS:
To find out the root cause, we performed following activities:
·
Purchased
same batch number product (coded as batch-A) from the same medical shop in
Udupi.
·
Purchased
different batch number product (coded as batch-B) from the same medical shop in
Udupi to cross check any observations related to formulation defects.
·
Performed
few important quality control tests like weight variation, friability and
hardness for both the batches.
Weight Variation Test:
20 tablets of each batch were individually weighed and average
weight of 20 tablets of each batch was calculated. Then each tablet was
compared with average weight of that batch and the percentage deviation from
the average tablet weight of that batch was calculated [6].
Friability:
Tablets weight equivalent to 6.5 g of each batch were taken
separately and subjected to friability test for 4 minutes at 25 rpm. After that
tablets were reweighed and percentage friability was calculated [6].
Hardness:
3 tablets of each batch were evaluated with respect to their
hardness using Monsanto hardness tester and the average hardness value of each
batch was reported [7].
RESULTS:
Friability:
Friability values for both the batches were well within the limits
as per IP 2007.
For batch A:
Initial weight of tablets = 6.623g
Final weight of tablets = 6.598g
Initial weight- final weight
% Friability= ----------------------------------
X 100
Initial weight
6.623-6.598
=
----------------------------- X100
6.623
= 0.377%
For batch B:
Initial weight of tablets = 6.657g
Final weight of tablets = 6.639g
Initial weight- final weight
% Friability=
---------------------------------- X 100
Initial weight
6.657-6.539
=
----------------------------- X100
6.657
= 0.377%
= 0.271%
Weight Variation:
All the tablets of both the batches were within the limits as per
IP 2007 with respect to weight variation test. The results are shown in the
Table 3. Percentage deviation was calculated using the following equation.
Individual weight- average weight
% Deviation =
----------------------------------------- X 100
average weight
Hardness:
The average hardness for both the batches of tablets was found to
be 9kg/cm2. The results are mentioned in the Table 4.
Table
3: Weight variation test :
|
Batch A |
Batch B |
||
S. No. |
Initial weight(mg) |
% deviation |
Initial weight(mg) |
% deviation |
1 |
610 |
0.60 |
603 |
-0.07 |
2 |
607 |
0.11 |
596 |
-1.23 |
3 |
602 |
-0.72 |
602 |
-0.24 |
4 |
610 |
0.60 |
605 |
0.26 |
5 |
603 |
-0.55 |
599 |
-0.74 |
6 |
601 |
-0.88 |
609 |
0.92 |
7 |
605 |
-0.22 |
600 |
-0.57 |
8 |
609 |
0.44 |
596 |
-1.23 |
9 |
605 |
-0.22 |
607 |
0.59 |
10 |
613 |
1.10 |
600 |
-0.57 |
11 |
609 |
0.44 |
609 |
0.92 |
12 |
602 |
-0.72 |
614 |
1.75 |
13 |
611 |
0.77 |
606 |
0.42 |
14 |
608 |
0.27 |
601 |
-0.41 |
15 |
600 |
-1.05 |
598 |
-0.90 |
16 |
611 |
0.77 |
601 |
-0.41 |
17 |
604 |
-0.39 |
611 |
1.25 |
18 |
609 |
0.44 |
600 |
-0.57 |
19 |
607 |
0.11 |
604 |
0.09 |
20 |
601 |
-0.88 |
608 |
0.75 |
Table
4: Hardness of both batches
S.No. |
Batch
A(kg/cm2) |
Batch
B(kg/cm2) |
1 |
9 |
9 |
2 |
9 |
9 |
3 |
9 |
9 |
Average |
9 |
9 |
DISCUSSIONS:
·
Both
Batch A and Batch B passed the weight variation test as per Indian Pharmacopeia
2010.
·
Friability
of Batch A was found to be 0.377% and Friability of Batch B was found to be
0.271%.
·
Hardness
of both batches of the tablet was found to be 9 kg.
CONCLUSION:
There was no formulation defect in the Batch-A tablets. Breakage
of the tablet at the edge must be due to some physical damage or some other
reason. This was concluded from results of friability, weight variation and
hardness tests. Appearance of black color spots on the tablet surface was not
due to formulation problem. It may be due to instrumental problems like
excessive use of oil- Based Lubricants etc. Finally to sum up, it is
recommended to carry out 100% tablet inspection before primary packing activity
which shall avoid defective tablets getting packed into blister.
REFERENCES
1.
Vamshi Krishna T., Girish Pai K., Sreenivasa Reddy M.,Kishan Y.S.S., Aditya, V.,
Bhanuprakash G., Vishnu Datta M., 2012.Study
on the Effectiveness of Various Types of Primary Packaging on the Physical
Parameters of Telmisartan Uncoated Tablets. Research J. Pharm. and
Tech., 5 (7), 962-967.
2.
Girish Pai K., Vamshi Krishna T.,
Sreenivasa Reddy M., Kishan Y.S.S., Aditya V., Bhanuprakash G.,
Vishnu DattaM., 2012.Physical evaluation of the uncoated tablets of Glimepiride with
different types of primary packaging. Research J. Pharm. and
Tech., 5 (3), 404-407.
3.
Girish Pai K., Vamshi Krishna T.,
LalitKumar, Sreenivasa Reddy M., Shreenidhi G., Praneeth Reddy A., 2013.Comparative evaluation of the physical parameters of
uncoated tablets of Amlodipine Besylate with different types of primary
packaging materials. Asian Journal of Pharmaceutical Research, 3
(1), 03-05.
4.
Vamshi Krishna T., Girish Pai K., Hemanth G.,
Damodaram A., Sreenivasa
Reddy M., 2013.Study of Various
Physical Parameters of Marketed Products of Paracetamol. Research
Journal of Pharmaceutical Dosage Forms and Technology, 5 (4), 227-231.
5.
Vamshi Krishna T., Lalit Kumar, Sreenivasa Reddy M.,
Muddukrishna B.S., Girish Pai K., 2013. Market complaints in Pharmaceuticals: A
Brief review on its handling, investigation and reporting. Research J. Pharm. and Tech., 6(11),
1314-1316.
6.
Lachman L., Lieberman H.A.,
Kanig L.J., 2009. The Theory and Practice of Industrial Pharmacy. Special
Indian ed., CBS Publishers and Distributers Pvt. Ltd., New Delhi.
7.
Pharmaceutical Methods, General
Chapters, 2007, Volume 1, 5th ed., Indian Pharmacopoeia, Ministry of
H and F, Govt. of India.